Real-world evidence (RWE) plays an important role in healthcare decisions as it offers a better representation of a diverse real-world population and the impact of treatment or intervention on the same. Several multinational and country-specific registries such as the British Association of Dermatologists Biologics and lmmunomodulators Register (BADBIR), Corrona, and DERMBIO have been generating RWE worldwide for biologics and immunomodulators available for the treatment of psoriasis (PsO). Eli Lilly and Docplexus have organized an interactive Webinar on 11 th June 2020 at 3:00 pm GST.
In this webinar session, Prof. Christopher E.M. Griffiths will share the following insights: Importance of RWE data, its interpretation, and role in regulatory decision making Safety and effectiveness outcomes of BADBIR Overview of other PsO registries such as Corrona and DERMBIO The vision of the…
